Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2002 | 2018 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 2002 | 2018 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 2005 | 2019 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
group | 0.040 | None | 1.000 | 4 | 0 | 1999 | 2018 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
group | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2015 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2003 | 2015 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 2002 | 2002 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
phenotype | 0.020 | None | 1.000 | 2 | 0 | 2013 | 2014 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1999 | 1999 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 1994 | 1994 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 2002 | 2002 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | < 0.001 | 1 | 0 | 1999 | 1999 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
group | 0.010 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 1 | 2002 | 2002 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||
|
ABL proto-oncogene 2, non-receptor tyrosine kinase | 0.619 | 0.654 | 3.6E-07 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 |